Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Glaukos Corp (GKOS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6413
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such as microstent devices to treat glaucoma such as iStent trabecular micro-bypass stent for the treatment of mild- tomoderate open-angle glaucoma. Glaukos’ iStent is used in conjunction with cataract surgery. Glauko’s iStent improves outflow by creating a patent bypass between the anterior chamber and Schlemm’s canal. The company markets its products through a network of distributors in Germany, Italy, Canada, Portugal, Spain, the UK and France, among others. Glaukos is headquartered in San Clemente, California, the US.

Glaukos Corp (GKOS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Glaukos Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Glaukos Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Glaukos Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Glaukos Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Glaukos Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Glaukos Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
Glaukos Acquires IOP Sensor System from DOSE Medical 10
Venture Financing 11
Glaukos Raises US$30 Million In Series F Financing 11
Glaukos Raises US$6 Million In Venture Financing 13
Glaukos Raises US$4.5 Million In Venture Financing 14
Partnerships 15
Glaukos Enters into Development Agreement with D. Western Therapeutics Institute 15
Equity Offering 16
Glaukos Raises USD124.2 Million in IPO 16
Glaukos Corp – Key Competitors 18
Glaukos Corp – Key Employees 19
Glaukos Corp – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 02, 2018: Glaukos reports second quarter 2018 financial results 21
May 09, 2018: Glaukos Announces First Quarter 2018 Financial Results 22
Feb 28, 2018: Glaukos Reports Fourth Quarter and Full Year 2017 Financial Results 23
Nov 07, 2017: Glaukos Announces Third Quarter 2017 Financial Results 24
Aug 02, 2017: Glaukos Announces Second Quarter 2017 Financial Results 25
May 03, 2017: Glaukos Announces First Quarter 2017 Financial Results 26
Mar 01, 2017: Glaukos Announces Fourth Quarter & Full Year 2016 Financial Results 27
Corporate Communications 28
Feb 22, 2017: Preeminent Ophthalmologist, L. Jay Katz Joins Glaukos as Chief Medical Officer 28
Feb 06, 2017: Joseph Gilliam to Join Glaukos Corporation as Chief Financial Officer and Senior Vice President of Corporate Development 29
Feb 01, 2017: Glaukos Promotes Chris M. Calcaterra to Chief Operating Officer 30
Product News 31
Feb 27, 2018: Glaukos Technologies Featured in Numerous Presentations at 2018 American Glaucoma Society Meeting 31
Sep 14, 2017: Glaukos to Outline Growth Strategy at Investor Day 33
May 01, 2017: Several Surgeon Presentations to Include Glaukos Technologies at 2017 American Society of Cataract and Refractive Surgery 35
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Glaukos Corp, Medical Equipment, Key Facts, 2017 2
Glaukos Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Glaukos Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Glaukos Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Glaukos Corp, Deals By Market, 2012 to YTD 2018 8
Glaukos Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Glaukos Acquires IOP Sensor System from DOSE Medical 10
Glaukos Raises US$30 Million In Series F Financing 11
Glaukos Raises US$6 Million In Venture Financing 13
Glaukos Raises US$4.5 Million In Venture Financing 14
Glaukos Enters into Development Agreement with D. Western Therapeutics Institute 15
Glaukos Raises USD124.2 Million in IPO 16
Glaukos Corp, Key Competitors 18
Glaukos Corp, Key Employees 19
Glaukos Corp, Subsidiaries 20

List of Figures
Glaukos Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Glaukos Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Glaukos Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Glaukos Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Glaukos Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sunland Group Ltd:企業の戦略・SWOT・財務情報
    Sunland Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Sunland Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Co-Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • Cardiva Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Cardiva Medical Inc (Cardiva) designs, develops and commercializes of vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures; and …
  • Multiplicom NV-医療機器分野:企業M&A・提携分析
    Summary Multiplicom NV (Multiplicom) is a molecular diagnostic company that develops, manufactures and markets genetic test kits. The company offers onco genetics, human genetics and prenatal genetics products. Its human genetics products are used for cancer genetics, genetic disorders and neurologi …
  • Four Seasons Hotels and Resorts:企業の戦略的SWOT分析
    Four Seasons Hotels and Resorts - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Saft Groupe SA:企業の戦略的SWOT分析
    Saft Groupe SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Hycor Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Hycor Biomedical Inc (Hycor) is a medical device company that manufactures and markets in-vitro diagnostic products. The company offers products such as auto immune testing systems, allergy testing systems, HYTEC plus and HYCOR ultrasensitive EIA products. Its auto immune testing products co …
  • Metabolomic Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Technologies Inc (MTI) is a diagnostic company that develops metabolomic-based diagnostic systems. The company's products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastroint …
  • Abeona Therapeutics Inc (ABEO):医療機器:M&Aディール及び事業提携情報
    Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associ …
  • William Hill PLC:企業の戦略・SWOT・財務分析
    William Hill PLC - Strategy, SWOT and Corporate Finance Report Summary William Hill PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company’s products include an …
  • TearLab Corp (TEAR):医療機器:M&Aディール及び事業提携情報
    Summary TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. The company …
  • Rutherford Electric Membership Corp:企業の戦略的SWOT分析
    Rutherford Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Globe Specialty Metals, Inc.:企業の戦略・SWOT・財務分析
    Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Key Energy Services Inc (KEG):石油・ガス:M&Aディール及び事業提携情報
    Summary Key Energy Services Inc (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, fi …
  • Assystem SA (ASY)-エネルギー分野:企業M&A・提携分析
    Summary Assystem S.A. (Assystem) is a provider of engineering and innovation consultancy services. Through coordinating with clients, the company designs and develops across the life cycle products and services. It offers various R&D services range from functional analysis to commissioning by design …
  • Wesfarmers Ltd (WES):企業の財務・戦略的SWOT分析
    Wesfarmers Ltd (WES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • EPAM Systems Inc (EPAM):企業の財務・戦略的SWOT分析
    EPAM Systems Inc (EPAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • RPG Cables Limited:企業の戦略・SWOT・財務情報
    RPG Cables Limited - Strategy, SWOT and Corporate Finance Report Summary RPG Cables Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Red Lion Hotels Corporation:企業の戦略・SWOT・財務情報
    Red Lion Hotels Corporation - Strategy, SWOT and Corporate Finance Report Summary Red Lion Hotels Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆